The FDA Silently Sanctions Broad Use of Anti-Psychotic Medication in Children

Thursday, August 23, 2007
By: Byron J. Richards,
Board Certified Clinical Nutritionist

If any person was ever looking for evidence that the medical profession and the FDA were beholden to the drug companies at the expense of human health, the use of anti-psychotic medication in our children is the classic example.  On August 22, 2007 the FDA approved Johnson & Johnson’s atypical anti-psychotic drug Risperdal for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar disorder in children and adolescents ages 10 to 17.  In so doing the FDA has silently condoned the use of this class of powerful brain-altering drug to be given for off label use to treat temper tantrums and behavioral outbursts in children of all ages.  This is sick beyond comprehension.  Medical doctors and psychiatrists who rampantly give out this medication for off label use are to be condemned.

The FDA approval was based on two paltry 6-8 week studies that showed improvement in symptoms.  Big deal – symptom management compared to the long term damage to the nervous system and fueling the production of obesity and diabetes is a crime against children.  Big Pharma is going after the brains of our children as a perverted profit center, raking in billions per year (mostly at taxpayer expense) while damaging the health and well being of our nation’s most valuable resource.  For the full story read Fight for Your Health: Exposing the FDA’s Betrayal of America.

The FDA should have put its foot down on the blatant overuse of these medications in our children with no evidence of safety and plenty of evidence of extremely adverse side effects.  Instead, this FDA action will result in even more billions of dollars of these poisonous drugs being used as a substitute for parenting and a decent diet.

FDA approved Johnson & Johnson’s atypical anti-psychotic drug Risperdal for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar disorder in children and adolescents ages 10 to 17. In so doing the FDA has silently condoned the use of this class of powerful brain-altering drug to be given for off label use to treat temper tantrums and behavioral outbursts in children of all ages. This is sick beyond comprehension..." class="pin-it-button" count-layout="vertical">

More Health Freedom News

Pulling Data...
Loading Navigation...
Loading Content...

View complete Health Freedom News Archives
E-mail:
Supplement Advisor
Wellness Resources Success Stories
Connect on Facebook Follow us on Twitter Wellness Resources on Pinterest Wellness Resources YouTube Channel Get RSS News Feeds